Movano Inc. (MOVE), Monday announced that the pulse oximeter in the company's EvieMED Ring has received 510(k) clearance from the U.S. Food and Drug Administration.
The company explained that the ring keeps track of blood oxygen level, heart rate, sleep activity, temperature variability, calories burned and respiration rate.
Upon receiving the clearance, the healthcare company can pursue opportunities in health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring for both healthcare providers and payors.
Currently, Movano's stock is trading at $5.51, down 2.36 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.